The State Medical Board of Ohio discussed petitions it received to add qualifying conditions to Ohio’s Medical Marijuana Control Program during its June 12, 2019 meeting. The board voted to reject the petitions for depression, insomnia and opioid use disorder but decided to table votes on autism spectrum disorder and anxiety for additional discussion and review. Ohio Administrative Code 4731-32-05 allows the board to extend its six-month decision deadline if it determines good cause. Dr. Michael Schottenstein stated that the board should postpone a vote because the two new board members have not had adequate time to consider the more than 2,000 pages of petitions and expert reports about the conditions. The Medical Marijuana Expert Review Committee completed its review of the expert reports on May 8, 2019. The committee voted to recommend autism spectrum disorder and anxiety to the full board. Click here to view the experts' reports . Under Ohio law, all of the following are already identified as qualifying medical conditions: AIDS, amyotrophic lateral sclerosis, Alzheimer’s disease, cancer, chronic traumatic encephalopathy, Crohn’s disease, epilepsy or another seizure disorder, fibromyalgia, glaucoma, hepatitis C, inflammatory bowel disease, multiple sclerosis, pain that is either chronic and severe or intractable, Parkinson’s disease, positive status for HIV, post-traumatic stress disorder, sickle cell anemia, spinal cord disease or injury, Tourette’s syndrome, traumatic brain injury, and ulcerative colitis. These conditions were established by lawmakers in HB523. The legislation also tasked the Medical Board with adding additional conditions. The board is set to accept new petitions for additional conditions Nov. 1 through Dec. 31, 2019. A condition that has been rejected by the board will not be reconsidered unless new information, such as additional research or supporting evidence, is provided.